{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T22:49:20Z","timestamp":1780440560161,"version":"3.54.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T00:00:00Z","timestamp":1766620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T00:00:00Z","timestamp":1766620800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Human Cell"],"DOI":"10.1007\/s13577-025-01336-2","type":"journal-article","created":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T07:19:53Z","timestamp":1766647193000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Neuroprotective activity of thiolutin in epileptic mice: the inhibition of NLRP3 inflammasome"],"prefix":"10.1007","volume":"39","author":[{"given":"Jiadong","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caili","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,25]]},"reference":[{"issue":"4","key":"1336_CR1","doi-asserted-by":"publisher","first-page":"Itc49","DOI":"10.7326\/annals-25-00494","volume":"178","author":"KB Krishnamurthy","year":"2025","unstructured":"Krishnamurthy KB. Epilepsy. Ann Intern Med. 2025;178(4):Itc49-itc64. https:\/\/doi.org\/10.7326\/annals-25-00494.","journal-title":"Ann Intern Med"},{"issue":"1","key":"1336_CR2","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/epi4.12686","volume":"8","author":"J Liu","year":"2023","unstructured":"Liu J, Zhang P, Zou Q, Liang J, Chen Y, Cai Y, et al. Status of epilepsy in the tropics: an overlooked perspective. Epilepsia Open. 2023;8(1):32\u201345. https:\/\/doi.org\/10.1002\/epi4.12686.","journal-title":"Epilepsia Open"},{"key":"1336_CR3","doi-asserted-by":"publisher","first-page":"1418926","DOI":"10.3389\/fneur.2024.1418926","volume":"15","author":"T Shan","year":"2024","unstructured":"Shan T, Zhu Y, Fan H, Liu Z, Xie J, Li M, et al. Global, regional, and national time trends in the burden of epilepsy, 1990\u20132019: an age-period-cohort analysis for the global burden of disease 2019 study. Front Neurol. 2024;15:1418926. https:\/\/doi.org\/10.3389\/fneur.2024.1418926.","journal-title":"Front Neurol"},{"issue":"2","key":"1336_CR4","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s00401-015-1481-5","volume":"131","author":"A Vezzani","year":"2016","unstructured":"Vezzani A, Fujinami RS, White HS, Preux PM, Bl\u00fcmcke I, Sander JW, et al. Infections, inflammation and epilepsy. Acta Neuropathol. 2016;131(2):211\u201334. https:\/\/doi.org\/10.1007\/s00401-015-1481-5.","journal-title":"Acta Neuropathol"},{"issue":"Suppl 1","key":"1336_CR5","doi-asserted-by":"publisher","first-page":"S73","DOI":"10.1002\/epi4.12610","volume":"8","author":"ML L\u00f3pez-Meraz","year":"2023","unstructured":"L\u00f3pez-Meraz ML, \u00c1lvarez-Croda DM. Microglia and status epilepticus in the immature brain. Epilepsia Open. 2023;8(Suppl 1):S73-s81. https:\/\/doi.org\/10.1002\/epi4.12610.","journal-title":"Epilepsia Open."},{"issue":"10","key":"1336_CR6","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.3390\/biomedicines11102825","volume":"11","author":"L Palumbo","year":"2023","unstructured":"Palumbo L, Carinci M, Guarino A, Asth L, Zucchini S, Missiroli S, et al. The NLRP3 inflammasome in neurodegenerative disorders: insights from epileptic models. Biomedicines. 2023;11(10):2825. https:\/\/doi.org\/10.3390\/biomedicines11102825.","journal-title":"Biomedicines"},{"issue":"8","key":"1336_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0271995","volume":"17","author":"MS Pohlentz","year":"2022","unstructured":"Pohlentz MS, M\u00fcller P, Cases-Cunillera S, Opitz T, Surges R, Hamed M, et al. Characterisation of NLRP3 pathway-related neuroinflammation in temporal lobe epilepsy. PLoS ONE. 2022;17(8):e0271995. https:\/\/doi.org\/10.1371\/journal.pone.0271995.","journal-title":"PLoS ONE"},{"key":"1336_CR8","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.neuroscience.2024.03.029","volume":"546","author":"J Chen","year":"2024","unstructured":"Chen J, Gao Y, Liu N, Hai D, Wei W, Liu Y, et al. Mechanism of NLRP3 inflammasome in epilepsy and related therapeutic agents. Neuroscience. 2024;546:157\u201377. https:\/\/doi.org\/10.1016\/j.neuroscience.2024.03.029.","journal-title":"Neuroscience"},{"key":"1336_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112247","volume":"134","author":"T Zhao","year":"2024","unstructured":"Zhao T, Zhang X, Cui X, Su S, Li L, Chen Y, et al. Oridonin exerts anticonvulsant profile and neuroprotective activity in epileptic mice by inhibiting NLRP3-mediated pyroptosis. Int Immunopharmacol. 2024;134:112247. https:\/\/doi.org\/10.1016\/j.intimp.2024.112247.","journal-title":"Int Immunopharmacol"},{"key":"1336_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2024.114794","volume":"377","author":"T Zhao","year":"2024","unstructured":"Zhao T, Zhang X, Cui X, Su S, Li L, Chen Y, et al. Inhibiting the IRAK4\/NF-\u03baB\/NLRP3 signaling pathway can reduce pyroptosis in hippocampal neurons and seizure episodes in epilepsy. Exp Neurol. 2024;377:114794. https:\/\/doi.org\/10.1016\/j.expneurol.2024.114794.","journal-title":"Exp Neurol"},{"issue":"11","key":"1336_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25116078","volume":"25","author":"I Haque","year":"2024","unstructured":"Haque I, Thapa P, Burns DM, Zhou J, Sharma M, Sharma R, et al. NLRP3 inflammasome inhibitors for antiepileptogenic drug discovery and development. Int J Mol Sci. 2024;25(11):6078. https:\/\/doi.org\/10.3390\/ijms25116078.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"1336_CR12","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s00221-023-06566-0","volume":"241","author":"Y Jia","year":"2023","unstructured":"Jia Y, Xue K, Luo Y, Liu C. Thiolutin attenuates ischemic stroke injury via inhibition of NLRP3 inflammasome: an in vitro and in vivo study. Exp Brain Res. 2023;241(3):839\u201349. https:\/\/doi.org\/10.1007\/s00221-023-06566-0.","journal-title":"Exp Brain Res"},{"issue":"11","key":"1336_CR13","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/s41419-023-06268-z","volume":"14","author":"W Zhang","year":"2023","unstructured":"Zhang W, Liu K, Ren GM, Wang Y, Wang T, Liu X, et al. BRISC is required for optimal activation of NF-\u03baB in Kupffer cells induced by LPS and contributes to acute liver injury. Cell Death Dis. 2023;14(11):743. https:\/\/doi.org\/10.1038\/s41419-023-06268-z.","journal-title":"Cell Death Dis"},{"issue":"58","key":"1336_CR14","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abe2933","volume":"6","author":"GM Ren","year":"2021","unstructured":"Ren GM, Li J, Zhang XC, Wang Y, Xiao Y, Zhang XY, et al. Pharmacological targeting of NLRP3 deubiquitination for treatment of NLRP3-associated inflammatory diseases. Sci Immunol. 2021;6(58):eabe2933. https:\/\/doi.org\/10.1126\/sciimmunol.abe2933.","journal-title":"Sci Immunol"},{"key":"1336_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.111236","volume":"126","author":"Y Hong","year":"2024","unstructured":"Hong Y, Wei C, Fu M, Li X, Zhang H, Yao B. MCC950 alleviates seizure severity and angiogenesis by inhibiting NLRP3\/ IL-1\u03b2 signaling pathway-mediated pyroptosis in mouse model of epilepsy. Int Immunopharmacol. 2024;126:111236. https:\/\/doi.org\/10.1016\/j.intimp.2023.111236.","journal-title":"Int Immunopharmacol"},{"key":"1336_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.114440","volume":"152","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Shi S, Lin C, Zeng Q, Che L, Li Y, et al. Thiolutin, a novel NLRP3 inflammasome inhibitor, mitigates IgA nephropathy in mice. Int Immunopharmacol. 2025;152:114440. https:\/\/doi.org\/10.1016\/j.intimp.2025.114440.","journal-title":"Int Immunopharmacol"},{"issue":"7","key":"1336_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.877","volume":"11","author":"A Wang","year":"2023","unstructured":"Wang A, Ma X, Wei F, Li Y, Liu Q, Zhang H. Evidence on the therapeutic role of thiolutin in imiquimod-induced psoriasis-like skin inflammation in mice. Immunity Inflamm Dis. 2023;11(7):e877. https:\/\/doi.org\/10.1002\/iid3.877.","journal-title":"Immunity Inflamm Dis"},{"issue":"3","key":"1336_CR18","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/0013-4694(72)90178-2","volume":"32","author":"R Racine","year":"1972","unstructured":"Racine R, Okujava V, Chipashvili S. Modification of seizure activity by electrical stimulation. 3. Mechanisms. Electroencephalogr Clin Neurophysiol. 1972;32(3):295\u20139. https:\/\/doi.org\/10.1016\/0013-4694(72)90178-2.","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"1336_CR19","doi-asserted-by":"publisher","DOI":"10.3791\/897","volume":"19","author":"J Nunez","year":"2008","unstructured":"Nunez J. Morris water maze experiment. J Vis Exp. 2008;19:897. https:\/\/doi.org\/10.3791\/897.","journal-title":"J Vis Exp"},{"key":"1336_CR20","doi-asserted-by":"publisher","DOI":"10.3791\/55718","volume":"126","author":"LM Lueptow","year":"2017","unstructured":"Lueptow LM. Novel object recognition test for the investigation of learning and memory in mice. J Vis Exp. 2017;126:55718. https:\/\/doi.org\/10.3791\/55718.","journal-title":"J Vis Exp"},{"issue":"1","key":"1336_CR21","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/epi.17433","volume":"64","author":"W L\u00f6scher","year":"2023","unstructured":"L\u00f6scher W, Stafstrom CE. Epilepsy and its neurobehavioral comorbidities: insights gained from animal models. Epilepsia. 2023;64(1):54\u201391. https:\/\/doi.org\/10.1111\/epi.17433.","journal-title":"Epilepsia"},{"issue":"2","key":"1336_CR22","doi-asserted-by":"publisher","DOI":"10.1523\/eneuro.0337-20.2021","volume":"8","author":"E Rusina","year":"2021","unstructured":"Rusina E, Bernard C, Williamson A. The kainic acid models of temporal lobe epilepsy. ENeuro. 2021;8(2):ENEURO.0337-20.2021. https:\/\/doi.org\/10.1523\/eneuro.0337-20.2021.","journal-title":"ENeuro"},{"issue":"1","key":"1336_CR23","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s12974-024-03167-8","volume":"21","author":"M Javalgekar","year":"2024","unstructured":"Javalgekar M, Jupp B, Vivash L, O\u2019Brien TJ, Wright DK, Jones NC, et al. Inflammasomes at the crossroads of traumatic brain injury and post-traumatic epilepsy. J Neuroinflamm. 2024;21(1):172. https:\/\/doi.org\/10.1186\/s12974-024-03167-8.","journal-title":"J Neuroinflamm"},{"issue":"1","key":"1336_CR24","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41573-023-00822-2","volume":"23","author":"L Vande Walle","year":"2024","unstructured":"Vande Walle L, Lamkanfi M. Drugging the NLRP3 inflammasome: from signalling mechanisms to therapeutic targets. Nat Rev Drug Discov. 2024;23(1):43\u201366. https:\/\/doi.org\/10.1038\/s41573-023-00822-2.","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"1336_CR25","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1535-7511.2007.00165.x","volume":"7","author":"A Vezzani","year":"2007","unstructured":"Vezzani A, Baram TZ. New roles for interleukin-1 beta in the mechanisms of epilepsy. Epilepsy Curr. 2007;7(2):45\u201350. https:\/\/doi.org\/10.1111\/j.1535-7511.2007.00165.x.","journal-title":"Epilepsy Curr"},{"issue":"43","key":"1336_CR26","doi-asserted-by":"publisher","first-page":"10278","DOI":"10.1523\/jneurosci.1301-17.2017","volume":"37","author":"I Bertani","year":"2017","unstructured":"Bertani I, Iori V, Trusel M, Maroso M, Foray C, Mantovani S, et al. Inhibition of IL-1\u03b2 signaling normalizes NMDA-dependent neurotransmission and reduces seizure susceptibility in a mouse model of Creutzfeldt-Jakob disease. J Neurosci. 2017;37(43):10278\u201389. https:\/\/doi.org\/10.1523\/jneurosci.1301-17.2017.","journal-title":"J Neurosci"},{"key":"1336_CR27","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.nbd.2013.07.015","volume":"59","author":"FM Noe","year":"2013","unstructured":"Noe FM, Polascheck N, Frigerio F, Bankstahl M, Ravizza T, Marchini S, et al. Pharmacological blockade of IL-1\u03b2\/IL-1 receptor type 1 axis during epileptogenesis provides neuroprotection in two rat models of temporal lobe epilepsy. Neurobiol Dis. 2013;59:183\u201393. https:\/\/doi.org\/10.1016\/j.nbd.2013.07.015.","journal-title":"Neurobiol Dis"},{"key":"1336_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.904225","volume":"13","author":"S Zhang","year":"2022","unstructured":"Zhang S, Chen F, Zhai F, Liang S. Role of HMGB1\/TLR4 and IL-1\u03b2\/IL-1R1 signaling pathways in epilepsy. Front Neurol. 2022;13:904225. https:\/\/doi.org\/10.3389\/fneur.2022.904225.","journal-title":"Front Neurol"},{"key":"1336_CR29","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.yebeh.2015.04.047","volume":"49","author":"JA Gorter","year":"2015","unstructured":"Gorter JA, van Vliet EA, Aronica E. Status epilepticus, blood-brain barrier disruption, inflammation, and epileptogenesis. Epilepsy Behav. 2015;49:13\u20136. https:\/\/doi.org\/10.1016\/j.yebeh.2015.04.047.","journal-title":"Epilepsy Behav"},{"issue":"1","key":"1336_CR30","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12974-022-02482-2","volume":"19","author":"Z Qin","year":"2022","unstructured":"Qin Z, Song J, Lin A, Yang W, Zhang W, Zhong F, et al. GPR120 modulates epileptic seizure and neuroinflammation mediated by NLRP3 inflammasome. J Neuroinflamm. 2022;19(1):121. https:\/\/doi.org\/10.1186\/s12974-022-02482-2.","journal-title":"J Neuroinflamm"},{"issue":"19","key":"1336_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e38050","volume":"10","author":"H Wang","year":"2024","unstructured":"Wang H, Ma Y, Jin D, Yang X, Xu X. Ulinastatin modulates NLRP3 inflammasome pathway in PTZ-induced epileptic mice: a potential mechanistic insight. Heliyon. 2024;10(19):e38050. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e38050.","journal-title":"Heliyon"},{"key":"1336_CR32","doi-asserted-by":"publisher","first-page":"6143","DOI":"10.2147\/jir.S469451","volume":"17","author":"L Wang","year":"2024","unstructured":"Wang L, Wang K, Chen Y, Zhang X, Xu W, Dong Z, et al. NLRP3 inflammasome inhibition after pilocarpine-induced status epilepticus attenuates chronic inflammation in epileptic mice. J Inflamm Res. 2024;17:6143\u201358. https:\/\/doi.org\/10.2147\/jir.S469451.","journal-title":"J Inflamm Res"}],"container-title":["Human Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-025-01336-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13577-025-01336-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-025-01336-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T07:19:54Z","timestamp":1766647194000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13577-025-01336-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,25]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["1336"],"URL":"https:\/\/doi.org\/10.1007\/s13577-025-01336-2","relation":{},"ISSN":["1749-0774"],"issn-type":[{"value":"1749-0774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,25]]},"assertion":[{"value":"10 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The Local Committees of the Use of Laboratory Animals at Affiliated Hospital of Shandong Second Medical University granted ethical approval for all animal experiments (No.: 2024SDL380), which were implemented following the guidelines and regulations for animal research established by the National Natural Science Foundation of China.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"28"}}